; or (ii) the amount of compensation the person received or was offered for the conduct constituting the violation. (B) Rule of construction A civil penalty under this subsection shall be in addition to any other criminal or civil statutory, common law, or administrative remedy available to the United States or any other person. (3) Injunctive relief (A) In general In a civil action brought under paragraph (1) against a person, the Attorney General may petition the court for an order prohibiting the person from engaging in conduct that violates section 602 or 603. (B) Standard The court may issue an order under subparagraph (A) if the court finds by a preponderance of the evidence that the conduct of the person violates section 602 or 603. (C) Rule of construction The filing of a petition seeking injunctive relief under this paragraph shall not preclude any other remedy that is available by law to the United States or any other person. . 3. Slowing the revolving door from pharmaceutical regulatory agency into private sector representational activities (a) In general Section 207 of title 18, United States Code, is amended— (1) by redesignating subsections (e) through (l) as subsections (f) through (m), respectively; and (2) by inserting after subsection (d) the following: (e) Restrictions on employment for pharmaceutical regulators (1) In general In addition to the restrictions set forth in subsections (a), (b), (c), and (d), a covered pharmaceutical regulator shall not— (A) during the 2-year period beginning on the date on which his or her employment as a covered pharmaceutical regulator ceases— (i) knowingly act as agent or attorney for, or otherwise represent, any other person for compensation (except the United States) in any formal or informal appearance before; (ii) with the intent to influence, make any oral or written communication on behalf of any other person (except the United States) to